Resistant MS Spasticity Treatment with Sativex and Driving

Trial Profile

Resistant MS Spasticity Treatment with Sativex and Driving

Phase of Trial: Phase IV

Latest Information Update: 29 Aug 2017

At a glance

  • Drugs Nabiximols (Primary)
  • Indications Muscle spasticity
  • Focus Pharmacodynamics
  • Sponsors Almirall S.A.
  • Most Recent Events

    • 28 Apr 2014 Status changed from active, no longer recruiting to completed as reported by German Clinical Trials Register.
    • 02 Oct 2013 Results have been presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) according to a GW Pharmaceuticals media release.
    • 20 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top